Publications:

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.

Jci Insight

Seidel, Philipp P; Rubarth, Anne A; Zodel, Kyra K; Peighambari, Asin A; Neumann, Felix F; Federkiel, Yannick Y; Huang, Hsin H; Hoefflin, Rouven R; Adlesic, Mojca M; Witt, Christian C; Hoffmann, David J DJ; Metzger, Patrick P; Lindemann, Ralph K RK; Zenke, Frank T FT; Schell, Christoph C; Boerries, Melanie M; von Elverfeldt, Dominik D; Reichardt, Wilfried W; Follo, Marie M; Albers, Joachim J; Frew, Ian J IJ

Publication Date: 2022-11-22

Variant appearance in text: DDX10: V260del

PubMed Link: 36413415

Variant Present in the following documents:

• jciinsight-7-156087-s060.xlsx, sheet 6

View BVdb publication page